Obesity is a serious disease with many associated comorbidities and should be effectively treated. In many obese patients, treatment based on only lifestyle interventions may not result in desirable weight loss and the availability of effective complementary drug treatment would be desirable.

The special issue on pharmacologic treatment of obesity is now requesting submission of original research and review articles with main topics of interest including, but not limited to, animal and human studies of:

• New central and peripheral targets
• Mechanism of drug action
• Pharmacogenomics
• New biomarkers
• New/novel experimental study designs
• Randomized controlled clinical trials, including in selected populations
• Comorbidity effects
• Combination drug treatments
• Future perspectives

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jobes/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable: